Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Exagen (XGN) Accumulated Depreciation & Amortization (2018 - 2025)

Historic Accumulated Depreciation & Amortization for Exagen (XGN) over the last 8 years, with Q3 2025 value amounting to $6.8 million.

  • Exagen's Accumulated Depreciation & Amortization rose 2068.23% to $6.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.8 million, marking a year-over-year increase of 2068.23%. This contributed to the annual value of $6.0 million for FY2024, which is 421.22% up from last year.
  • Latest data reveals that Exagen reported Accumulated Depreciation & Amortization of $6.8 million as of Q3 2025, which was up 2068.23% from $6.4 million recorded in Q2 2025.
  • Exagen's 5-year Accumulated Depreciation & Amortization high stood at $6.8 million for Q3 2025, and its period low was $200000.0 during Q1 2021.
  • Over the past 5 years, Exagen's median Accumulated Depreciation & Amortization value was $5.6 million (recorded in 2024), while the average stood at $4.4 million.
  • Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first skyrocketed by 213600.0% in 2022, then crashed by 1367.56% in 2024.
  • Exagen's Accumulated Depreciation & Amortization (Quarter) stood at $900000.0 in 2021, then skyrocketed by 77.78% to $1.6 million in 2022, then surged by 260.56% to $5.8 million in 2023, then rose by 4.21% to $6.0 million in 2024, then grew by 12.39% to $6.8 million in 2025.
  • Its last three reported values are $6.8 million in Q3 2025, $6.4 million for Q2 2025, and $6.1 million during Q1 2025.